Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Nelarabine + fludarabine has significant activity, acceptable toxicity in refractory leukemias

Dec. 4, 2000

CDK-inhibitory pyrazolobenzodiazepines for cancer

Dec. 4, 2000

GEM-231 can be safely used with taxanes in advanced cancer patients according to phase I data

Dec. 1, 2000

Favorable preclinical results for huN901-DM1/BB-10901 support rapid advance to clinic

Dec. 1, 2000

CRC describes new prodrugs for cancer ADEPT or GDEPT

Dec. 1, 2000

Positive preliminary response rate reported for RSR-13 in NSCLC

Dec. 1, 2000

Bristol-Myers Squibb seeks FDA approval to begin systemic CA4P trials

Dec. 1, 2000

Abgenix and Immunex join forces for development of anticancer antibodies

Dec. 1, 2000

Scotia submits additional data to FDA for Foscan NDA

Nov. 30, 2000

U.K. scientists investigate novel series of antitumor agents

Nov. 30, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...